Literature DB >> 15634614

Design and in vitro evaluation of new drug-in-adhesive formulations of fentanyl transdermal patches.

Amir Mehdizadeh1, Tayebe Toliate, Mohammad Reza Rouini, Sharyar Abashzadeh, Farid Dorkoosh.   

Abstract

The present research was designed to evaluate different matrix, drug-in-adhesive and reservoir formulations of fentanyl transdermal patches. The target was to design drug-in-adhesive patches (DIAPs); a full factorial design was used. Different types and amounts of liquid, pressure-sensitive adhesives (PSAs) were used and evaluated with respect to drug release and adhesive properties. A very simple but precise method, the simplified peel 180 degrees test, was developed to measure and compare adhesive properties of transdermal patches. The results showed that release kinetics obeyed the square root of time or Higuchi model, indicating the diffusion controlled release mechanism. It was found that the amount of fentanyl needed for each 10 cm(2) three-days DIAP should be 3.3 mg. The respective amounts for reservoir and matrix patches were 2.5 and 5 mg. It was concluded that acrylic PSAs showed the best adhesion and release properties.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15634614

Source DB:  PubMed          Journal:  Acta Pharm        ISSN: 1330-0075            Impact factor:   2.230


  4 in total

1.  Reservoir based fentanyl transdermal drug delivery systems: effect of patch age on drug release and skin permeation.

Authors:  Suneela Prodduturi; Glen J Smith; Anna M Wokovich; William H Doub; Benjamin J Westenberger; Lucinda Buhse
Journal:  Pharm Res       Date:  2009-02-20       Impact factor: 4.200

2.  Preparation and in vitro evaluation of a new fentanyl patch based on functional and non-functional pressure sensitive adhesives.

Authors:  Seyed Mojtaba Taghizadeh; Arezou Soroushnia; Fatemeh Mohamadnia
Journal:  AAPS PharmSciTech       Date:  2010-02-25       Impact factor: 3.246

3.  Formulation development and in vitro and in vivo evaluation of membrane-moderated transdermal systems of ampicillin sodium in ethanol: pH 4.7 buffer solvent system.

Authors:  Janardhanan Bagyalakshmi; Ramachandra Purapu Vamsikrishna; Rajappan Manavalan; Thengungal Kochupappy Ravi; Probal Kumar Manna
Journal:  AAPS PharmSciTech       Date:  2007-01-26       Impact factor: 3.246

4.  Development of mesophasic microreservoir-based transdermal drug delivery system of propranolol.

Authors:  L K Omray; S Kohli; A J Khopade; S Patil; Asmita Gajbhiye; G P Agrawal
Journal:  Indian J Pharm Sci       Date:  2008-09       Impact factor: 0.975

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.